Faq
A：DAWNRAYS was established on Dec.8th, 1995.
2、 Q：What are DAWNRAYS’ main products lines ?
A: DAWNRAYS engaged in R&D, manufacturing and marketing of Cephalosporin and various specialty drugs (generic drugs). It mainly creates and supplies a broad range of pharmaceuticals including Intermediates, APIs, and Formulations of Cephalosporin. For more details, please refer PRODUCT.
3、 Q：Where is DAWNRAYS located?
A：DAWNRAYS is a HONG KONG-based pharmaceutical enterprise which includes six subsidiaries.
l Suzhou Dawnrays Pharmaceutical Co., Ltd.
l Suzhou Dawnrays Chemical Co., Ltd.
l Shanghai Dawnrays Chemical Co., Ltd.
l Dawnrays (
l Dawnrays Pharma (
l Guangdong Dawnrays Pharmaceutical Co., Ltd
4、 Q：Does DAWNRAYS follow any official current Good Manufacturing Practices?
A：Yes. DAWNRAYS’ late update certificate of GMP for pharmaceutical product.
5、 Q：Is there any well-know advanced production process and technique in DAWNRAYS?
A：Yes. The quality of Solvent-crystallization technique in producing Cefoperazone has reached the international standard.
6、 Q：how much turnover and production capacity of DAWNRAYS?
A：The turnover was 1 billion RMB in 2007 and 800 tons of cephalosporins bulk drug per year.
7、 Q：What forms of payment does DAWNRAYS accept?
A：DAWNRAYS generally accepts T/T IN ADVANCE and L/C SIGHT. Any other form of payment should be confirmed with the related sales men.
8、 Q：What is the account for DAWNRAYS?
A：DAWNRAYS request the sender to instruct the remitting bank to use the following payment route:
l Beneficiary’s Bank Name in Hong Kong: BANK OF CHINA (
Beneficiary’s Name: DAWNRAYS PHARMA (HONG KONG) LIMITED
Beneficiary’s A/C No.: 01259592016515
SWIFT Code: BKCHHKHHXXX
l Beneficiary’s Bank Name in
Beneficiary’s Name: Suzhou Dawnrays Pharmaceutical Co., Ltd.
Beneficiary’s A/C No.: 1102026209914020834
SWIFT BIC: ICBKCNBJSZU
9、 Q：On what exchange does DAWNRAYS trade and what is its ticker symbol?
A： "HK2348" for the Main Board of Hong Kong Stock Exchange Market.
10 、 Q：How about DAWNRAYS’ R & D Center?
